International Journal of Frontiers in Medicine, 2023, 5(1); doi: 10.25236/IJFM.2023.050102.
Tao Peng1, Xilei Li2, Yongmei Yan3
1Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China
2China Medical University, Shenyang, Liaoning, China
3The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China
Xiaoyao Powder is composed of Radix Bupleuri, Radix Angelicae Sinensis, Radix Paeoniae Alba, Radix Glycyrrhizae, Rhizoma Atractylodis Macrocephalae, Poria, Ginger and Mentha haplocalyx. It has the effects of soothing liver and relieving depression, nourishing blood and invigorating spleen. It is a classic prescription for harmonizing liver and spleen and is widely used in clinical practice. Modern clinical studies have confirmed that this prescription has a good therapeutic effect on post-stroke depression, dementia, headache and other brain diseases, but its components are numerous, the mechanism of action is complex, and the research results are scattered. Therefore, the author focuses on the main treatment of brain diseases. Combined with the results of modern experimental research, the mechanism of action of the active components related to single herbs in the prescription and the clinical application of the compound application of the compound induction and collation, the mechanism of action and experimental research status of the prescription were further clarified, providing valuable reference for the majority of physicians in clinical application.
xiaoyao powder; brain diseases; mechanism of action
Tao Peng, Xilei Li, Yongmei Yan. Advances in clinical and experimental research on xiaoyao powder in brain disorders. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 1: 7-13. https://doi.org/10.25236/IJFM.2023.050102.
 Sun Haijun. The treatment of mental disorders with xiaoyao powder [J]. Shandong Journal of Traditional Chinese Medicine, 2005, (3): 179-180.
 Mark X., Su R., Fan J. P., et al. Exploring the source of prescriptions for Xiaoyao powder[J]. Shandong Journal of Traditional Chinese Medicine, 2014, 33(2): 88-90.
 Wang Huping, Wu Hongyan. A review of the functions of Xiaoyao powder[J]. Chinese Journal of Traditional Chinese Medicine Information, 2014, 21(1): 126-128.
 Lin Feiwu, Wang Anasazi, Rong Zhen, et al. Research on the pharmacological effects, chemical composition and development and utilization of Bupleurum album[J]. Asia-Pacific Traditional Medicine, 2020, 16(10): 202-205.
 Zhang JY, Zhang XJ. Experimental study on the effects of bupleurum saponin on acetylcholine metabolism and histomorphology in hippocampus of rats in depression model[J]. Journal of Qiqihar Medical College, 2011, 32(4): 506-508.
 Cai Zhenzhen, Xu Guangyou, Wen Qiuting, et al. Effects of bupleurum saponin on the behavior and hippocampal caspase-3 and caspase-9 protein expression in rats in a depression model[J]. Journal of Beijing University of Traditional Chinese Medicine, 2015, 38(2): 115-119, 149.
 Yu Liuqin, Jia Aimei, Song Yongyan. Advances in anti-inflammatory, antioxidant and lipid-lowering studies of Chaihu saponins[J]. Chinese Journal of Atherosclerosis, 2020, 28(1): 87-92.
 Zhang YL, Tian Y, Fu QF, et al. Advances in the chemical composition and pharmacological effects of Paeonia lactiflora[J]. Journal of Traditional Chinese Medicine, 2021, 49(2): 104-109.
 He Ni, Hou Yu, Bo Hui, et al. Study on the antidepressant and anti-inflammatory effects of Bai Shao extract [J]. World Journal of Integrated Chinese and Western Medicine, 2018, 13(3): 348-352.
 Yang Shanjing, Feng Anjie, Sun Yue,et al. Advances in the pharmacological effects and mechanisms of total peony glycosides[J]. Chinese Modern Applied Pharmacology, 2021, 38(13): 1627-1633.
 Ma YC, Wu WX, Hu JH, et al. Advances in the chemical composition and pharmacological effects of Angelica sinensis [J]. Journal of Traditional Chinese Medicine, 2022, 50(1): 111-114.
 Yunjie Xie, Haitao Zhang, Yang Zhang, et al. Chinese Angelica Polysaccharide (CAP) Alleviates LPS-Induced Inflammation and Apoptosis by Down-Regulating COX-1 in PC12 Cells[J]. Cellular Physiology and Biochemistry, 2018, 49(4): 1380-1388.
 Yuni Zhou, Xiaoqian Guo, Weimei Chen, et al. Angelica polysaccharide mitigates lipopolysaccharide-evoked inflammatory injury by regulating microRNA-10a in neuronal cell line HT22 [J]. Artificial Cells, Nanomedicine, and Biotechnology, 2019, 47(1): 3194-3201.
 Wang F L, Liu Z, Zhang L B, et al. Research progress on the anti-inflammatory and analgesic effects of Angelica sinensis [J]. Chinese Journal of Experimental Formulation, 2021, 27(15): 197-209.
 Du H, He W S, Hu H L, et al. Advances in the pharmacological effects of active ingredients of Atractylodes macrocephala [J]. Jiangsu Traditional Chinese Medicine, 2022, 54(5): 76-80.
 Chao Liu,Hong Zhao,Zhi-Hong Ji, et al. Neuroprotection of Atractylenolide III from Atractylodis macrocephalae Against Glutamate-Induced Neuronal Apoptosis Via Inhibiting Caspase Signaling Pathway[J]. Neurochemical Research, 2014, 39(9): 1753-1758.
 Qingxia Huang, Tingting Lou, Manying Wang, et al. Compound K inhibits autophagy-mediated apoptosis induced by oxygen and glucose deprivation/reperfusion via regulating AMPK-mTOR pathway in neurons[J]. Life Sciences, 2020, 254: 117793.
 Hu WX, Xiang Q, Wen Z, et al. Study on the mechanism of antihypoxic apoptosis of neural cells by Atractylodes macrocephala polysaccharide[J]. Pharmacology and Clinical Practice of Chinese Medicine, 2013, (4).
 Haiyan Gao, Xianghua Zhu, Yang Xi, et al. Anti-depressant-like effect of atractylenolide I in a mouse model of depression induced by chronic unpredictable mild stress[J]. Experimental and Therapeutic Medicine, 2018, 15(2): 1574-1579.
 Liu W, Deng LH, Zhao YQ. Overview of the pharmacological effects of Atractylodes macrocephala and its active ingredients[J]. Journal of Traditional Chinese Medicine, 2021, 49(10): 116-119.
 Kecheng Zhou, Jie Chen, Jiayu Wu, et al. Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in microglia[J]. Phytomedicine, 2019, 59: 152922.
 Du Xiaoyan, Wu Jiao. Progress in the study of chemical composition and pharmacological effects of Poria cocos[J]. Journal of Xinxiang Medical College, 2021, 38(5): 496-500.
 Li M.Y., Xu Y.B., Xu Z.L., et al. Study on the improvement of learning memory and sedative- hypnotic effects of Poria cocos[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2014, 16(5): 25-26.
 Chen Ketuo, Chen S, Ren Jieyi, et al. Study on the antidepressant effect of Poria acidic polysaccharide and its mechanism of regulating neurotransmitter and NLRP3 pathway[J]. Chinese Journal of Traditional Chinese Medicine, 2021, 46(19): 5088-5095.
 Yu W B, Li R J, Cui C, et al. Study on the anxiolytic effect of Poria cocos based on the pathological model [J]. Chinese Pharmacology and Clinical Practice, 2021, 37(5): 74-79.
 Wang B, Wang L, Liu XF, et al. Research progress on the composition and pharmacological effects of Glycyrrhiza glabra and its modern clinical application[J]. Chinese medicine, 2022, 17(2): 316-320.
 Han Weiwei, Fang Dongjun, Li Lujun, et al. Advances in chemical composition and biological activity of Glycyrrhiza glabra[J]. Chemical Engineer, 2022, 36(2): 56-58, 67.
 Muhammad Usman Mirza,A. Hammad Mirza,Noor-ul-Huda Ghori, et al. Glycyrrhetinic acid and E.resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson& rsquo;s disease: a& nbsp;pharmacoinformatics study [J]. Drug Design, Development and Therapy, 2015, 9: 187-198.
 Weixing Wang,Xinying Hu,Zhiyu Zhao, et al. Antidepressant-like effects of liquiritin and isoliquiritin from Glycyrrhiza uralensis in the forced swimming test and tail suspension test in mice[J]. Progress in Neuro-psychopharmacology and Biological Psychiatry, 2008, 32(5): 1179-1184.
 Weiwei Tao,Yu Dong,Qiang Su, et al. Liquiritigenin reverses depression-like behavior in unpredictable chronic mild stress-induced mice by regulating PI3K/Akt/mTOR mediated BDNF/TrkB pathway[J]. Behavioural Brain Research, 2016, 308: 177-186.
 ZHANG Shujuan, ZHANG Yugui, XIN Erdan, et al. Advances in the pharmacological effects of ginger [J]. Journal of Gansu University of Traditional Chinese Medicine, 2020, 37(6): 79-81.
 Wang Xiaoli, Zhang Wei, Zhang Xueman, et al. Effect of ginger volatile oil on apoptosis of lysosomal-mitochondrial pathway in rats with cerebral ischemia-reperfusion[J]. New Drugs in Chinese Medicine and Clinical Pharmacology, 2020, 31(10): 1153-1157.
 Tian P, Zhang DW, Ma K, et al. Effects of total ginger phenol on focal cerebral ischemia model rats [J]. Chinese Pharmacology and Clinical Practice, 2017, 33(5): 70-73.
 ZHANG Liuchao,NIU Meilan,WANG Peng,et al. Effects of ginger on NHE1 and HIF-1α protein levels in brain tissue of rats with cerebral ischemia-reperfusion[J]. Chinese Journal of Traditional Chinese Medicine, 2020, 38(5): 41-44, 265-266.
 Yang R, Chen Xunhao, Li Jin, et al. Advances in chemical composition and pharmacological activity of Mentha piperita [J]. Journal of Tianjin University of Traditional Chinese Medicine, 2022, 41(1): 4-13.
 Speranta Avram,Maria Mernea,Eyup Bagci, et al. Advanced Structure-activity Relationships Applied to Mentha spicata L. Subsp. spicata Essential Oil Compounds as AChE and NMDA Ligands, in Comparison with Donepezil, Galantamine and Memantine – New Approach in Brain Disorders Pharmacology[J]. Cns & Neurological Disorders - Drug Targets, 2017, 16(7): 800-811.
 Liang Hao-Ming, Long Xiao-Ying, Lu Yao-Wen, et al. Effects of inhalation of peppermint oil on mental fatigue behavior and amino acid neurotransmitters in the brain of mice[J]. New Drugs in Chinese Medicine and Clinical Pharmacology, 2015, 26(5): 649-654.
 Qi S K, Gao J, Yu M Y, et al. Advances in the pathogenesis of post-stroke depression[J]. Stroke and Neurological Disorders, 2022, 29(5): 483-486.
 Fu Shaojing, Zhou Yanhua, Be Hongche, et al. Study on the therapeutic mechanism of xiaoyao powder in post-stroke depressed rats[J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2022, 39(5): 1135-1142.
 Wang Xiaoxia, Zhao Yingdan, Wang Mingli. Discussion on the clinical efficacy and some mechanisms of electro-item acupuncture combined with xiaoyao powder on post-stroke depression[J]. Journal of Clinical and Experimental Medicine, 2018, 17(2): 155-159.
 Zheng Qiaojuan. Clinical efficacy of xiaoyao powder combined with sertraline in the treatment of post-stroke depression [J]. Journal of Clinical Rational Drug Use, 2021, 14(32): 65-67.
 Li Chenjia, Zhang Qangrong. Efficacy of combining Chinese and Western medicine in the treatment of tension headache[J]. Chinese herbal medicine, 2009, 40(6): 945-946.
 Xie Wei, Zhu Chengquan, Chen Baotian. 46 cases of tension headache treated with Xin Zheng Tian Wan [J]. Journal of Anhui College of Traditional Chinese Medicine, 2000, (4): 18-20.
 Huang Nianbin, Qiu Lianqun. Treatment of 28 cases of tension headache with xiaoyao powder [J]. Journal of Practical Chinese Medicine, 2004, (5): 232.
 Lou Qi, Yu Le Duan, Ye Dan Xiao. Observation on the efficacy of Hei Yi Yao San plus reduction in the treatment of dementia in 60 cases [J]. Clinical Research in Chinese Medicine, 2019, 11(8): 90-91.
 Chen M.T., Xiao Jiao, Lin H.D., et al. Exploring the mechanism of action of xiaoyao powder on atherosclerosis and depression based on network pharmacology[J]. Chinese Journal of Traditional Chinese Medicine, 2020, 45(17): 4099-4111.
 Lei J, Zhang Q, Yuan FISHU, et al. The efficacy of xiaoyao powder of vertigo with the addition and subtraction of xiaoyao powder[J]. Chinese practical medicine, 2007, (2): 121-122.
 Yuan Shengping. The treatment of dizziness with the addition of xiaoyao powder [J]. Journal of Zunyi Medical College, 2002, (1): 75-77.
 Chen Zuo, Wang Dou, Ma Jianfu, et al. Progress of clinical and experimental research on Atractylodis Macrocephalae in brain diseases J]. Journal of Liaoning University of Traditional Chinese Medicine, 2022, 24(11): 67-72.